Result of AGM

RNS Number : 2274O

hVIVO plc

26 May 2015

 



For immediate release 12.00pm: 26 May 2015

HVIVO PLC

("hVIVO" or the "Company")

 

Result of Annual General Meeting

hVIVO plc (AIM: RVG), the pioneer of human challenge models of disease, is pleased to announce that all resolutions proposed at its Annual General Meeting, held at 10am on 21 May 2015, were duly passed.

For further information please contact:

hVIVO plc                                                                                          [phone]

Kym Denny (Chief Executive Officer)

Graham Yeatman (Chief Financial & Business Officer)

Media Enquiries                                                      [phone] / [phone]

Colin Paterson (Director of Marketing, Communication and Public Relations)

Numis Securities Limited                                                                      [phone]

Michael Meade / Freddie Barnfield (Nominated Adviser)

James Black / Michael Burke (Corporate Broking)

Notes to Editors:

hVIVO plc ("hVIVO") is a life sciences company pioneering a technology platform of human disease models to accelerate drug development and discovery in respiratory and infectious diseases.  Based in the UK, hVIVO has conducted over 40 clinical studies, involving more than 1950 volunteers for a range of leading industry, governmental and academic clients.

 

END

 

 

RAGPKADPKBKDOPB